Skip to Content

The Medical Letter on Drugs and Therapeutics
Objective, peer-reviewed evaluations of new FDA-approved drugs, and new information on previously approved drugs.
January 23, 2012 (Issue 1382)
  • Afilbercept (Eylea) for Age-Related Macular Degeneration
  • PDE5 Inhibitors for Erectile Dysfunction Revisited
  • Etonogestrel (Nexplanon) Contraceptive Implant
Treatment Guidelines from The Medical Letter
Unbiased reviews of drug classes used to treat common disorders. Includes the doses, adverse effects and the recommendations of expert reviewers.
February 2012 (Issue 114)
  • Inhalation is the preferred route of delivery for most asthma drugs. Chlorofluorocarbons (CFCs), which have ozone-depleting properties, are being phased out as propellants in metered-dose inhalers. Non-chlorinated hydrofluoroalkane (HFA) propellants, which do not deplete the ozone layer,... [more]
  • Drugs for Inflammatory Bowel Disease
  • Drugs for Tuberculosis